Jane Street’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.26M Buy
32,900
+21,000
+176% +$1.19M ﹤0.01% 4953
2026
Q1
$764K Sell
11,900
-46,300
-80% -$4.22M ﹤0.01% 7083
2025
Q4
$7.57M Sell
58,200
-63,000
-52% -$8.65M ﹤0.01% 2672
2025
Q3
$13.1M Sell
121,200
-315,900
-72% -$34.4M ﹤0.01% 2087
2025
Q2
$40.3M Buy
437,100
+413,200
+1,729% +$32.4M 0.01% 906
2025
Q1
$2.12M Buy
+23,900
New +$2.07M ﹤0.01% 4259
2022
Q2
– Sell
-4,924
Closed -$499K – 11035
2022
Q1
$499K Buy
4,924
+4,251
+632% +$473K ﹤0.01% 7492
2021
Q4
$99K Buy
673
+34
+5% +$7.6K ﹤0.01% 9261
2021
Q3
$160K Buy
639
+312
+95% +$107K ﹤0.01% 9019
2021
Q2
$151K Buy
+327
New +$140K ﹤0.01% 9043

Other funds holding WGS

Jane Street's WGS Position: Q2 2026 in Review

Jane Street opened a new position in GeneDx Holdings (WGS) in Q2 2026: 204,592 shares worth $14M. The stake represents ﹤0.01% of the portfolio and ranks #2463 among its holdings. This is a return to the name: Jane Street previously reported a position in WGS as recently as Q4 2025.

Jane Street first reported a position in WGS in Q2 2021 and has held it in 16 quarters since. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Jane Street held 204,592 shares of GeneDx Holdings worth $14M as of Q2 2026.
  • GeneDx Holdings was a new Jane Street position in Q2 2026.
  • GeneDx Holdings made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #2463 holding.
  • Jane Street first reported a position in GeneDx Holdings in Q2 2021 and has held it in 16 quarters since.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.